Vanhauwaert, Dimitri
Silversmit, Geert
Vanschoenbeek, Katrijn
Coucke, Gregory
Di Perri, Dario
Clement, Paul M.
Sciot, Raf
De Vleeschouwer, Steven
Boterberg, Tom
De Gendt, Cindy
Article History
Received: 15 June 2024
Accepted: 9 July 2024
First Online: 2 August 2024
Declarations
:
: SDV is a certified Gliolan (Medac GmbH) Trainer and has performed consultancy for Lamepro NV (Gliolan) for which a fee was received. PC has performed consultancy for Bayer, BMS, Leo pharma, Merck, MSD, Rakuten Medical and Servier, and serves as a member of the CTG/CRM in Belgium. All other authors have no relevant financial or non-financial interests to disclose.
: This study was approved by the Ethics Committee of Ghent University Hospital (DA 2020-042). Written informed consent from participants was not required in accordance with local/national guidelines.